Virtual Presentation

Master Class in Management of Liver Metastases From Colorectal Cancer: Case-Based Learning

Source: Master Class in Management of Liver Metastases From Colorectal Cancer

Master Class in Management of Liver Metastases From Colorectal Cancer: Case-Based Learning


Program Director: Steven R. Alberts, MD

Faculty:

  • Steven R. Alberts, MD

CME CREDIT INFORMATION

Release Date: 04/15/08

Expiration Date: 04/14/09


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain changes in the criteria for determining resectability in patients with liver metastases from colorectal cancer
  • Discuss current categorization of systemic therapeutic approaches (adjuvant, neoadjuvant, and conversion therapy) for treating and improving survival in colorectal cancer patients with liver metastases
  • Identify systemic treatment regimens that have been studied in conversion therapy in colorectal cancer patients with liver metastases
  • Discuss a multidisciplinary approach to liver metastases in colorectal cancer that optimizes treatment in the individual patient to achieve the best possible outcome while minimizing chemotherapy toxicity, surgical morbidity, and other adverse events

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.